Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/2005
09/29/2005CA2559280A1 Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing
09/29/2005CA2558635A1 Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast
09/29/2005CA2558269A1 Sequence capable of accelerating gene expression at moderately low temperature
09/29/2005CA2557436A1 Polymer-ceramic-hydrogel composite scaffold for osteochondral repair
09/28/2005EP1580273A1 Peptide-based method for monitoring gene expression in a host cell
09/28/2005EP1580272A2 TAT transdominant variants of human immunodeficiency virus (HIV)
09/28/2005EP1580271A2 Human Orphan G Protein-Coupled Receptors
09/28/2005EP1579209A2 Device and method for non-invasive measurement of the individual metabolic rate of a substantially spherical metabolizing particle
09/28/2005EP1579011A2 Modulation of death-associated protein kinase 1 expression
09/28/2005EP1579006A2 Modulation of jagged 1 expression
09/28/2005EP1578992A2 Methods of determining precise herg interactions and aletring compounds based on said interactions
09/28/2005EP1578991A2 Methods of diagnosing & treating diabetes and insulin resistance
09/28/2005EP1578988A2 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
09/28/2005EP1578987A2 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
09/28/2005EP1578983A2 Methods for regulating co-stimulatory molecule expression with reactive oxygen
09/28/2005EP1578981A2 Tumor endothelial marker 7alpha molecules and uses thereof
09/28/2005EP1578976A2 Plants having modified growth characteristics and a method for making the same
09/28/2005EP1578973A1 Plant cells and plants which synthesize a starch with an increased final viscosity
09/28/2005EP1578960A1 Magnetism based rapid cell separation
09/28/2005EP1578958A2 Method for suppressing immune system response to transplanted tissue or cells
09/28/2005EP1578957A1 Formable and settable polymer bone composite and method of production thereof
09/28/2005EP1578956A2 Highly permissive cell lines for hepatitis c virus replication
09/28/2005EP1578955A2 Candida kefyr cytosine deaminase
09/28/2005EP1578926A2 Novel prostate tumor-specific promoter
09/28/2005EP1578925A2 Methods for in vitro expansion and transdifferentiation of human pancreatic acinar cells into insulin-producing cells
09/28/2005EP1578917A2 Multimeric proteins and methods of making and using same
09/28/2005EP1578914A2 Human ion channels
09/28/2005EP1578913A2 Nucleic acids and proteins of insect or83b odorant receptor genes and uses thereof
09/28/2005EP1578912A2 Il-13 mutein proteins, antibodies, compositions, methods and uses
09/28/2005EP1578911A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
09/28/2005EP1578909A2 Excitatory glycine receptors and methods
09/28/2005EP1578906A2 Afap sequences, polypeptides, antibodies and methods
09/28/2005EP1578905A2 Novel proteins and nucleic acids encoding same
09/28/2005EP1578902A2 Neurotransmission-associated proteins
09/28/2005EP1578899A2 Secreted proteins
09/28/2005EP1578897A2 Process for inducing functional tolerance to gene transfer products
09/28/2005EP1578789A1 Nucleic acid comprising a sequence encoding a modified glutenin polypeptide
09/28/2005EP1578772A2 Cytokines and cytokine receptors with reduced immunogenicity
09/28/2005EP1578760A2 Compositions and methods for the diagnosis and treatment of tumor
09/28/2005EP1578446A2 Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same
09/28/2005EP1578396A2 Methods and compositions concerning poxviruses and cancer
09/28/2005EP1578385A2 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
09/28/2005EP1578380A2 Compositions and methods for the therapy and diagnosis of prostate cancer
09/28/2005EP1578368A2 Compositions and methods for the treatment of rheumatoid arthritis
09/28/2005EP1578367A2 Compositions and methods for the treatment of immune related diseases
09/28/2005EP1578347A2 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
09/28/2005EP1578345A2 Peptides and antibodies to muc 1 proteins
09/28/2005EP1578200A1 Cell-based vegf delivery
09/28/2005EP1578197A2 Composition and method for treating lupus nephritis
09/28/2005EP1578194A2 Biological assays using gradients formed in microfluidic systems
09/28/2005EP1465489A4 Methods of expressing lim mineralization protein in non-osseous cells
09/28/2005EP1436393A4 Rapid method of selecting cells for gene disruption by homologous recombination
09/28/2005EP1423695A4 Androgen receptor knock-out transgenic animals
09/28/2005EP1356277A4 Method for altering cell fate
09/28/2005EP1263787B1 G-protein coupled receptor
09/28/2005EP1129194B1 Interleukin-1 homolog zil1a4
09/28/2005EP1037991B1 Cell surface glycoproteins associated with human b cell lymphomas - ulbp, dna and polypeptides
09/28/2005EP0991763B1 Modified adenoviral fiber and target adenoviruses
09/28/2005EP0767835B1 Denervated muscle kinase (dmk), a receptor of the tyrosine kinase super family
09/28/2005CN1675542A Isolation and identification of T cells
09/28/2005CN1675383A Method and apparatus for decarburization of molten steel
09/28/2005CN1675366A Plastid genetic engineering via somatic embryogenesis
09/28/2005CN1675359A Novel forms of interfering rna molecules
09/28/2005CN1675355A Novel lipases and uses thereof
09/28/2005CN1675354A In vitro fertilisation
09/28/2005CN1675353A Substances for preventing and treating autoimmune diseases
09/28/2005CN1675351A Advanced roller bottle system for cell and tissue culturing
09/28/2005CN1675245A Monoclonal antibody hPAM4
09/28/2005CN1675240A Variants of the major allergen phl p 1 from timothy grass
09/28/2005CN1675237A Immunogenic compositions
09/28/2005CN1674923A Non-polymeric hematopoeitic cell clots for delivery of active agents
09/28/2005CN1674879A Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
09/28/2005CN1674780A Low pressure sperm cell separation system
09/28/2005CN1674778A Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids
09/28/2005CN1673361A Multipotential cell containing heterogenous nuclear and mitochondrion
09/28/2005CN1673360A Complex organ-like precursor with culture device and structure thereof and culturing method
09/28/2005CN1673359A Program induction method for promoting embryonic stem cell directional differentiation to hemopoietic stem cell
09/28/2005CN1673358A Method for separating mesenchy mall stem/ancestral cells for bone parenchyma
09/28/2005CN1673357A Method for digesting blood smooth muscle
09/28/2005CN1673356A A method for in vitro derivativing nerve stem cell directional differentiation to cholinergic neuron
09/28/2005CN1673355A A method for establishing insect cell line
09/28/2005CN1673232A Receptor DR5 monoclonal antibody (AD5-10) resisting human tumor necrosin related apoptosis inducing ligand and its prepn and use
09/28/2005CN1673231A Monoclonal antibody of SARS coronavirus N protein and its application
09/28/2005CN1220778C Method of preceeding gene conversion against orchid using micropellet bombardment
09/28/2005CN1220772C Method for separating silk gland cell of silkworm suited to researches in molecular biology
09/28/2005CN1220771C Method of proceeding gene conversion against orchid using agriculturel bacillus induction
09/28/2005CN1220767C Cellular environment liquid changing device
09/27/2005US6950754 Apparatus and method for automated protein design
09/27/2005US6949699 Genetic engineering or inbreeding to obtain corn seeds and plants, having herbicide, insect and disease resistance
09/27/2005US6949626 Bacillus thuringiensis cryET33 and cryET34 compositions and uses therefor
09/27/2005US6949520 Methods related to immunostimulatory nucleic acid-induced interferon
09/27/2005US6949512 administering to patient effective amount of lipopolysaccharide binding protein to elevate serum concentration of lipopolysaccharide binding protein in patient to sufficiently high level to suppress lipopolysaccharide induced release of cytokine
09/27/2005US6949382 for providing biochemical analysis of antioxidant function in human lymphocytes
09/27/2005US6949381 Immortalized human skin cell lines and novel serum-free medium useful for the production thereof
09/27/2005US6949380 culturing a proliferating epidermal basal cell population, exposing the cell(s) to fetuin, noggin, chordin, gremlin, follistatin, growing the cell(s) in the presence of an antisense oligonucleotide antagonist of bone morphogenetic protein (BMP)
09/27/2005US6949378 C. elegans gro-1 gene
09/27/2005US6949366 Complexing; purified polypeptide
09/27/2005US6949361 Polynucleotide
09/27/2005US6949357 Reagents and methods useful for detecting diseases of the urinary tract
09/27/2005US6949355 Methods, compositions, and automated systems for separating rare cells from fluid samples